| Antibiotic utilization in Iran 2000–2016: pattern analysis and benchmarking with organization for economic co-operation and development countries H Abbasian, M Hajimolaali, A Yektadoost, S Zartab Journal of research in pharmacy practice 8 (3), 162-167, 2019 | 37 | 2019 |
| Fundamentals and Stock Return in Pharmaceutical Companies: a Panel Data Model of Iranian Industry: Hydrogel based tablet for vaginal candidiasis A Kebriaee-zadeh, S Zartab, SF Fatemi, R Radmanesh Iranian Journal of Pharmaceutical Sciences 9 (1), 55-60, 2013 | 23 | 2013 |
| The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016 S Zartab, NN Koopaei, H Abbasian, MN Koopaei, NN Koopaei Journal of Pharmaceutical Policy and Practice 13 (1), 50, 2020 | 6 | 2020 |
| A systematic review of discrete choice experiment studies in rheumatoid arthritis biological medicines S Zartab, S Nikfar, N Karimpour-Fard, A Jamshidi, V Varahrami, ... Mediterranean Journal of Rheumatology 32 (2), 104, 2021 | 4 | 2021 |
| Despite affordability, low utilization of lipid lowering drugs in Iran: Trend analysis and benchmarking 2005-2016 S Zartab, H Abbassian, NN Koopaei, M Hajimolaali Iranian Journal of Pharmaceutical Research: IJPR 18 (2), 1117, 2019 | 1 | 2019 |
| Evaluation of Health Sector in the 5-year Socioeconomic and Cultural Cevelopment Plans of Iran H Abbasian, A Kebriaeizadeh, M Toroski, S Zartab Journal of Pharmacoeconomics and Pharmaceutical Management, 2023 | | 2023 |
| Affordability After Subsidy Shift from Parallel Exchange Rate to Insurance: a Retrospective Cross Sectional Study H Abbasian, S Zartab Journal of Pharmacoeconomics and Pharmaceutical Management, 2023 | | 2023 |
| How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment S Zartab, S Nikfar, A Jamshidi, M Toroski, V Varahrami, B Fatemi, ... Expert Review of Pharmacoeconomics & Outcomes Research 23 (6), 701-708, 2023 | | 2023 |
| Status and Performance of Health System in The Socio-Economic and Cultural Development Plans of Iran H Abbasian, A Kebriaeizadeh, M Toroski, S Zartab Journal of Pharmacoeconomics and Pharmaceutical Management 9 (4), 1-7, 2023 | | 2023 |
| Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride J Khedmati, F Soleymani, A Moosivand, S Zartab, M Seyedifar Iranian Journal of Pharmaceutical Research: IJPR 20 (1), 206, 2021 | | 2021 |
| PIN49-THE COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VERSUS CASPOFUNGIN FOR CANDIDEMIA AND INVASIVE CANDIDIASIS TREATMENT: AN EXPERIENCE FROM IRAN M Afzali, S Zartab, P Zaboli, S Nikfar, M Boorboor Value in Health 21, S229, 2018 | | 2018 |
| Evaluation of Health Care Reform Impact on Cancer PatientsAccess To Medicine: A Pilot-Center Experience in Islamic Republic of Iran M Mansoori, P Zaboli, M Saeedi, G Janbabai, S Nikfar, E Rohani, S Zartab Value in Health 20 (9), A879, 2017 | | 2017 |
| Iranian Pharmaceutical Industry Opportunities in Iraq AHM Al Iami, S Zartab, M Jaberidoost, A Yektadoost, S Nikfar, ... Journal of Pharmacoeconomics and Pharmaceutical Management 3 (3/4), 35-40, 2017 | | 2017 |
| Journal of Pharmacoeconomics and Pharmaceutical Management H Abbasian, A Kebriaeizadeh, M Toroski, S Zartab, A Shiva, M Divanbeigi, ... | | |
